IMV - IMV Inc. (IMV) CEO Frederic Ors on Q3 2020 Results - Earnings Call Transcript

IMV Inc. (IMV) Q3 2020 Earnings Conference Call November 12, 2020 08:00 ET Company Participants Pierre Labbé - CFO Frederic Ors - CEO Neil Berinstein - Hematologist & Affiliate Scientist, Sunnybrook Institute Joanne Schindler - CMO Conference Call Participants Jim Birchenough - Wells Fargo Securities Tom Shrader - BTIG Ted Tenthoff - Piper Sandler David Novak - Raymond James Eduardo Garcia - National Bank Financial Presentation Operator Good morning, ladies and gentlemen, and welcome to the IMV's Presentation of Data on Relapsed Refractory DLBCL Treated with DPX-Survivac, Low Dose Cyclophosphamide and Pembrolizumab, which will be combined with the presentation of IMV third-quarter results and highlights. At this time, all lines are in a listen-only mode. After each presentation, there will be a question and answer session and instructions will be provided at that time in order to queue up for questions. [Operator Instructions] I would now like to turn the

For further details see:

IMV Inc. (IMV) CEO Frederic Ors on Q3 2020 Results - Earnings Call Transcript